Single-antibiotic use for penetrating abdominal trauma

Area of Science:

• Infectious Diseases
• Surgical Infections
• Pharmacology

Background:

• Penetrating abdominal trauma presents a high risk of intra-abdominal infections.
• Effective antibiotic prophylaxis is crucial in managing these complex surgical cases.
• Comparing novel antibiotics with established regimens is essential for optimizing patient care.

Purpose of the Study:

• To compare the efficacy of moxalactam disodium against a combination of clindamycin phosphate and tobramycin sulfate.
• To evaluate the incidence of intra-abdominal infections in patients with penetrating abdominal trauma.
• To assess the safety profile of moxalactam, specifically regarding coagulopathies.

Main Methods:

• Prospective randomized study involving 190 patients with penetrating abdominal trauma.
• Patients were treated with either moxalactam disodium or clindamycin/tobramycin.
• Outcomes assessed included intra-abdominal infection rates and bleeding complications.

Main Results:

• No significant difference in intra-abdominal infection rates between moxalactam (13%) and clindamycin/tobramycin (9%) groups.
• Patients with colon injuries had a higher infection rate (21%) compared to those without (6%), irrespective of antibiotic regimen.
• No moxalactam-related bleeding issues were observed; coagulopathies were linked to shock and massive transfusion.

Conclusions:

• Moxalactam disodium demonstrates comparable efficacy to the combination of clindamycin and tobramycin for penetrating abdominal trauma.
• Antibiotic choice did not significantly alter infection rates in patients with colon injuries.
• Moxalactam is a safe and effective alternative for antibiotic prophylaxis in this patient population.